About this trial
This study compares the automated anesthesia systems for painless abortion (AAS-PA) with traditional anesthesia in painless abortions. It assesses intraoperative indicators (hypoxemia, injection pain, hypotension, hemodynamics, respiratory depression) and postoperative outcomes (nausea, dizziness, recovery time, satisfaction). The AAS-PA group uses AI-adjusted intravenous ciprofol based on real-time vital signs and sedation depth; the traditional group relies on manual anesthesia. The goal is to verify if AAS-PA safely manages sedation, meets painless standards, reduces adverse events, and improves experience, aiding optimized automated protocols.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age between 18-45 years
ASA status Ⅰ to Ⅱ
Diagnosed with early intrauterine pregnancy
Body mass index (BMI) between 18 to 28 kg/m2
Disqualifiers
History of cardiac, hepatic, renal, or metabolic disorders (e.g., diabetes, hypertension, sleep apnea)
Known allergy to opioids or ciprofloxacin components
Cachexia
History of substance or alcohol abuse
Trial design
Parallel
Treatments tested in this trial
AI Controlled General Anesthesia
Procedure/SurgeryDuring painless abortion, anesthesia will be induced using ciprofol, and controlled by an AI model.
General Anesthesia
Procedure/SurgeryAnesthesia will be induced using ciprofol, and controlled by experienced anesthesiologists.
Treatment groups
Trial outcomes
Primary outcomes
Incidence of Hypoxemia
Hypoxemia is defined as blood oxygen saturation below 92% at any time.
Secondary outcomes
Area under curve of hypoxemia
The area where SpO2 is below 92%.
Duration of colonoscopy
Lowest value of blood oxygen saturation
Induction and maintenance doses of anesthesia
Doses are recorded in mg/kg/h. The induction period is defined as the interval from the start of anesthesia to the first BIS value below 60. The maintenance period is defined as the interval from the first BIS value below 60 to the end of the drug infusion.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.
Lead sponsor
Fujian Provincial Hospital
Collaborator
Shishi Hospital
Collaborator
Sichuan Provincial People's Hospital
Collaborator
First Affiliated Hospital of the Chinese People's Liberation Army Naval Medical University
Collaborator
The People's Hospital of Yubei District of Chongqing city
Collaborator
Peking University Shenzhen Hospital
Collaborator
People's Hospital of Zhengzhou University
Collaborator
Jinjiang Municipal Hospital (Shanghai Sixth People's Hospital Fujian)
Collaborator
This trial is not recruiting at the moment. You can still explore other options: